SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-045670
Filing Date
2023-02-23
Accepted
2023-02-23 08:01:34
Documents
12
Period of Report
2023-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d468974d8k.htm   iXBRL 8-K 26154
  Complete submission text file 0001193125-23-045670.txt   149163

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20230222.xsd EX-101.SCH 2881
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20230222_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20230222_pre.xml EX-101.PRE 11283
6 EXTRACTED XBRL INSTANCE DOCUMENT d468974d8k_htm.xml XML 3361
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 23656005
SIC: 2834 Pharmaceutical Preparations